Disc Medicine announced a webcast on October 19, 2026, to discuss topline results from its APOLLO Phase 3 trial of bitopertin, an investigational oral drug for erythropoietic protoporphyria (EPP). Bitopertin targets glycine transporter 1 to modulate heme biosynthesis and could be the first disease-modifying therapy for EPP. The company acquired global rights to bitopertin from Roche in 2021 and has conducted multiple clinical trials including Phase 2 and Phase 3 studies. Investors and interested parties can register on Disc Medicine's website to attend the webcast and access a replay afterward.
Disc Medicine's webcast on APOLLO Phase 3 trial results offers context for readers. For those following the health sector, 29 of 150 US stocks rose, 118 fell. Notable movers include BNGO at USD 1.25 (-8.76%), SANA at USD 2.27 (-8.28%), and IBRX at USD 9.18 (-8.20%). Data as of Oct 19, 2026 04:02 WIB.
Tech analyst James Altucher draws a parallel between the 1865 coal consumption surge and AI's increasing power needs, despite efficiency gains. He highlights Elon Musk's unique strategy of vertical integration, including plans to build AI data center...
BitTorrent has completed its inaugural burn of BTT tokens, using 100% of decentralized service revenue to repurchase and permanently remove over 21.6 trillion tokens from circulation. This marks a key step in BitTorrent's long-term strategy to create...
Cardano's total stablecoin balances reached approximately $70.2 million as of October 18, marking a 31.1% increase over the past 30 days. The largest portion, about $44.54 million or 63.5%, is labeled as USD Coin (USDC), followed by Moneta’s USDM, Re...
Solana (SOL) experienced a price decline from around $112 to $103, marked by several daily spot-volume spikes classified as "heating"—a first in about six months. Previously, from December to early June, SOL's volume mostly showed "cooling" signals a...
Anthropic announced it will allocate 5% of its shares to a new public benefit fund aimed at supporting projects that benefit society. The fund, a wholly-owned entity within the company, may receive an additional 2% of shares for every 50% increase in...
